10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Winshine Science Co's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was -8.42%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Winshine Science Co's 10-Year ROIIC % or its related term are showing as below:
HKSE:00209's 10-Year ROIIC % is ranked worse than 73.59% of 765
companies
in the Travel & Leisure industry
Industry Median: 2.27
vs HKSE:00209: -8.42
Winshine Science Co 10-Year ROIIC % Historical Data
The historical data trend for Winshine Science Co's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Winshine Science Co's 10-Year ROIIC %
For the Leisure subindustry, Winshine Science Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winshine Science Co's 10-Year ROIIC % Distribution in the Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Winshine Science Co's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Winshine Science Co's 10-Year ROIIC % falls into.
Winshine Science Co 10-Year ROIIC % Calculation
Winshine Science Co's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Winshine Science Co (HKSE:00209) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Winshine Science Co 10-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Winshine Science Co's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Winshine Science Co (HKSE:00209) Business Description
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00209 has been successfully added to your 